11 /100
LOW RISK
Score updated May 29, 2026

NEPH — Nephros, Inc. Dilution Risk Tracker

Track NEPH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NEPH — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
12
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NEPH.
🔔 Track NEPH — Get forecast alerts →

💹 Market Data

Market Cap$40.17M
Shares Outstanding10.86M
Float8.83M
Cash$4.02M
Debt$968.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 5.7% shares (2025Q4 vs prior)
35 institutional holders · 5.30M shares
#1 WEXFORD CAPITAL LP 3.62M shares
#2 Topline Capital Management, LLC 614.3K shares
#3 VANGUARD GROUP INC 233.6K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest29.8K
Days to Cover1.2
% of Float0.3%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2022
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track NEPH Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NEPH — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for NEPH
📊 NEPH FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NEPH Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.